ROCKET PHARMACEUTICALS, INC.·4

Apr 2, 8:17 PM ET

Yalamanchi Naveen 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Apr 2, 2018

Insider Transaction Report

Form 4
Period: 2018-03-29
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-03-29+40,00040,000 total
    Exercise: $18.75Exp: 2028-03-29Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION